Celldex 制药 CLDX
$29.87 +$1.60 (+5.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.00 +0.44%
开盘$27.85
昨收$28.27
当日区间$27.82 – $30.15
成交量926.3K
市值$2.35B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$22,000.00-97.0% YoY
营业利润-$80.62M-26.3% YoY
净利润-$73.50M-29.9% YoY
摊薄每股收益-$0.94-10.6% YoY
自由现金流-$60.59M-35.4% YoY
经营现金流-$57.41M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-206,220.3%
净利率-190,220.9%
净资产收益率-43.9%
资产收益率-40.8%
投入资本回报率-43.6%
流动比率11.82
负债/资产比率8.7%
现金及投资$717.59M
总负债$3.35M
净现金（净负债）$714.24M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $22,000.00 | $15,000.00 | $1.55M | $121,000.00 | $0.00 |
| 营业总收入 | $22,000.00 | $15,000.00 | $1.55M | $121,000.00 | $0.00 |
| 营业费用 | $80.65M | $84.45M | $288.91M | $87.27M | $73.62M |
| 销售及管理费用 | $13.10M | $11.45M | $43.84M | $11.94M | $10.69M |
| -管理费用 | $13.10M | $11.45M | $43.84M | $11.94M | $10.69M |
| 研发费用 | $67.54M | $73.00M | $245.07M | $75.33M | $62.93M |
| 营业利润 | -$80.62M | -$84.44M | -$287.37M | -$87.15M | -$73.62M |
| 其他收入（支出） | $7.12M | $5.75M | $28.61M | $5.84M | $6.57M |
| 证券出售收益 | $7.12M | $5.75M | $28.61M | $5.84M | $6.57M |
| 税前利润 | -$73.50M | -$78.69M | -$258.76M | -$81.32M | -$67.04M |
| 净利润 | -$73.50M | -$78.69M | -$258.76M | -$81.32M | -$67.04M |
| 持续经营利润 | -$73.50M | -$78.69M | -$258.76M | -$81.32M | -$67.04M |
| 归属母公司净利润 | -$73.50M | -$78.69M | -$258.76M | -$81.32M | -$67.04M |
| 归属普通股股东净利润 | -$73.50M | -$78.69M | -$258.76M | -$81.32M | -$67.04M |
| 基本每股收益 | -$0.94 | -$1.18 | -$3.90 | -$1.22 | -$1.01 |
| 摊薄每股收益 | -$0.94 | -$1.18 | -$3.90 | -$1.22 | -$1.01 |
| 特殊收益（费用） | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $782.35M | $511.25M | $582.98M | $582.98M | $648.44M |
| 流动资产合计 | $724.93M | $459.22M | $534.66M | $534.66M | $604.34M |
| 现金及现金等价物与短期投资 | $717.59M | $451.46M | $518.57M | $518.57M | $583.22M |
| -现金及现金等价物 | $47.45M | $35.73M | $28.87M | $28.87M | $36.04M |
| -短期投资 | $670.13M | $415.73M | $489.70M | $489.70M | $547.19M |
| 应收款 | $230,000.00 | $230,000.00 | $2.02M | $2.02M | $90,000.00 |
| -应收账款 | $230,000.00 | $230,000.00 | $2.02M | $2.02M | $90,000.00 |
| 其他流动资产 | $7.11M | $7.53M | $14.08M | $14.08M | $21.03M |
| 非流动资产合计 | $57.42M | $52.03M | $48.32M | $48.32M | $44.10M |
| 固定资产净值 | $14.79M | $9.41M | $7.77M | $7.77M | $7.55M |
| -固定资产原值 | $14.79M | $9.41M | $31.68M | $31.68M | $7.55M |
| 一年以上预付资产 | $14.80M | $14.80M | $13.36M | $13.36M | $9.20M |
| 商誉及其他无形资产 | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M |
| -其他无形资产 | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M |
| 其他非流动资产 | $634,000.00 | $634,000.00 | – | – | $164,000.00 |
| 负债合计 | $67.79M | $55.03M | $55.82M | $55.82M | $50.08M |
| 流动负债合计 | $61.33M | $51.47M | $50.99M | $50.99M | $46.47M |
| 应付款 | $14.68M | $10.36M | $1.18M | $1.18M | $4.27M |
| -应付账款 | $14.68M | $10.36M | $1.18M | $1.18M | $4.27M |
| 一年内应计费用 | $43.86M | $38.42M | $47.03M | $47.03M | $39.72M |
| 短期债务及融资租赁负债 | $1.56M | $1.47M | $1.55M | $1.55M | $1.55M |
| -一年内到期融资租赁负债 | $1.56M | $1.47M | $1.55M | $1.55M | $1.55M |
| 其他流动负债 | $1.23M | $1.23M | $1.23M | $1.23M | $930,000.00 |
| 非流动负债合计 | $6.46M | $3.56M | $4.83M | $4.83M | $3.61M |
| 长期债务及融资租赁负债 | $3.35M | $443,000.00 | $784,000.00 | $784,000.00 | $1.07M |
| -长期融资租赁负债 | $3.35M | $443,000.00 | $784,000.00 | $784,000.00 | $1.07M |
| 其他非流动负债 | $3.11M | $3.11M | $4.04M | $4.04M | $2.54M |
| 股东权益合计 | $714.56M | $456.23M | $527.17M | $527.17M | $598.36M |
| 股东权益 | $714.56M | $456.23M | $527.17M | $527.17M | $598.36M |
| 股本 | $79,000.00 | $67,000.00 | $67,000.00 | $67,000.00 | $66,000.00 |
| -普通股 | $79,000.00 | $67,000.00 | $67,000.00 | $67,000.00 | $66,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.68B | $2.35B | $2.34B | $2.34B | $2.33B |
| 留存收益 | -$1.97B | -$1.89B | -$1.81B | -$1.81B | -$1.73B |
| 不影响留存收益的损益 | $1.30M | $2.52M | $3.63M | $3.63M | $3.77M |
| -累计折旧 | – | – | -$23.90M | -$23.90M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$57.41M | -$65.59M | -$210.95M | -$63.94M | -$48.63M |
| 持续经营经营活动现金流净额 | -$57.41M | -$65.59M | -$210.95M | -$63.94M | -$48.63M |
| 持续经营净利润 | -$73.50M | -$78.69M | -$258.76M | -$81.32M | -$67.04M |
| 持续经营损益 | $1,000.00 | $3,000.00 | $12,000.00 | $0.00 | $6,000.00 |
| 折旧、折耗与摊销 | $902,000.00 | $854,000.00 | $3.38M | $816,000.00 | $824,000.00 |
| 营运资金变动 | $8.48M | $4.35M | $14.06M | $8.53M | $9.80M |
| -应收款变动 | $0.00 | $1.79M | -$1.32M | -$1.93M | $0.00 |
| -预付资产变动 | -$1.17M | $6.28M | $8.71M | $8.47M | -$2.79M |
| -应付账款及应计费用变动 | $10.14M | -$287,000.00 | $11.03M | $4.60M | $13.06M |
| -其他流动资产变动 | $0.00 | -$2.08M | -$3.61M | -$3.99M | -$64,000.00 |
| -其他流动负债变动 | -$490,000.00 | -$1.36M | -$753,000.00 | $1.38M | -$410,000.00 |
| 投资活动现金流净额 | -$255.52M | $72.12M | $209.07M | $55.43M | $60.85M |
| 持续经营投资活动现金流净额 | -$255.52M | $72.12M | $209.07M | $55.43M | $60.85M |
| 固定资产购置及出售净额 | -$3.18M | -$1.64M | -$2.71M | -$1.28M | -$440,000.00 |
| 投资购置及出售净额 | -$252.34M | $73.76M | $211.79M | $56.71M | $61.29M |
| 筹资活动现金流 | $324.66M | $327,000.00 | $2.39M | $1.35M | $774,000.00 |
| 持续经营筹资活动现金流净额 | $324.66M | $327,000.00 | $2.39M | $1.35M | $774,000.00 |
| 普通股发行净额 | $323.83M | $0.00 | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $825,000.00 | $327,000.00 | $2.39M | $1.35M | $774,000.00 |
| 期末现金余额 | $47.45M | $35.73M | $28.87M | $28.87M | $36.04M |
| 现金净变动 | $11.73M | $6.86M | $515,000.00 | -$7.17M | $12.99M |
| 期初现金余额 | $35.73M | $28.87M | $28.36M | $36.04M | $23.04M |
| 自由现金流 | -$60.59M | -$67.23M | -$213.66M | -$65.22M | -$49.07M |
暂无评论——快来第一个聊聊 CLDX。
登录后参与讨论。